Find clinical trials for Lung Cancer in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near St Louis, MO, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Saint Louis, Missouri, United States and 83 other locations
This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell lung cancer...
Phase 2
Saint Louis, Missouri, United States and 47 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
Saint Louis, Missouri, United States and 11 other locations
(CT-STAR) to central and ultra-central early-stage non-small cell lung cancers on grade 3 or greater toxicity. Online adaptive radi...
Saint Louis, Missouri, United States
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Saint Louis, Missouri, United States and 198 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Saint Louis, Missouri, United States and 157 other locations
The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...
Phase 2
Saint Louis, Missouri, United States and 65 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...
Phase 1
Saint Louis, Missouri, United States and 25 other locations
results observed in participants with Extensive-stage Small Cell Lung Cancer (ES-SCLC) who received at least 1 prior line of platin...
Phase 2
Saint Louis, Missouri, United States and 100 other locations
In this study, patients with small cell or non-small cell lung cancer will receive ADI-PEG 20, gemcitabine, and docetaxel after dem...
Phase 1, Phase 2
Saint Louis, Missouri, United States
Clinical trials
Research sites
Resources
Legal